413 related articles for article (PubMed ID: 25403901)
21. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
[TBL] [Abstract][Full Text] [Related]
22. Genetic Counselors' Experience with and Opinions on the Management of Newborn Screening Incidental Carrier Findings.
Leppert K; Bisordi K; Nieto J; Maloney K; Guan Y; Dixon S; Egense A
J Genet Couns; 2018 Dec; 27(6):1328-1340. PubMed ID: 29687313
[TBL] [Abstract][Full Text] [Related]
23. Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization.
Eno C; Bayrak-Toydemir P; Bean L; Braxton A; Chao EC; El-Khechen D; Esplin ED; Friedman B; Hagman KDF; Hambuch T; Hernandez A; Juusola J; Londre G; Machado J; Mao R; Mighion L; Rehm HL; Ward P; Deignan JL
Genet Med; 2019 Apr; 21(4):861-866. PubMed ID: 30214068
[TBL] [Abstract][Full Text] [Related]
24. Secondary findings: How did we get here, and where are we going?
Ormond KE; O'Daniel JM; Kalia SS
J Genet Couns; 2019 Apr; 28(2):326-333. PubMed ID: 30821867
[TBL] [Abstract][Full Text] [Related]
25. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
Hampel H; Bennett RL; Buchanan A; Pearlman R; Wiesner GL;
Genet Med; 2015 Jan; 17(1):70-87. PubMed ID: 25394175
[TBL] [Abstract][Full Text] [Related]
26. Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.
Evans BJ
Genet Med; 2013 Dec; 15(12):915-20. PubMed ID: 24030435
[TBL] [Abstract][Full Text] [Related]
27. Genetics specialists' perspectives on disclosure of genomic incidental findings in the clinical setting.
Downing NR; Williams JK; Daack-Hirsch S; Driessnack M; Simon CM
Patient Educ Couns; 2013 Jan; 90(1):133-8. PubMed ID: 23068909
[TBL] [Abstract][Full Text] [Related]
28. Practical considerations in the clinical application of whole-exome sequencing.
Shashi V; McConkie-Rosell A; Schoch K; Kasturi V; Rehder C; Jiang YH; Goldstein DB; McDonald MT
Clin Genet; 2016 Feb; 89(2):173-81. PubMed ID: 25678066
[TBL] [Abstract][Full Text] [Related]
29. Current controversies in prenatal diagnosis 2: The 59 genes ACMG recommends reporting as secondary findings when sequencing postnatally should be reported when detected on fetal (and parental) sequencing.
Amor DJ; Chitty LS; Van den Veyver IB
Prenat Diagn; 2020 Dec; 40(12):1508-1514. PubMed ID: 32091628
[TBL] [Abstract][Full Text] [Related]
30. Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice.
Petrucelli N; Lazebnik N; Huelsman KM; Lazebnik RS
Genet Test; 2002; 6(2):107-13. PubMed ID: 12215249
[TBL] [Abstract][Full Text] [Related]
31. Clinical exome performance for reporting secondary genetic findings.
Park JY; Clark P; Londin E; Sponziello M; Kricka LJ; Fortina P
Clin Chem; 2015 Jan; 61(1):213-20. PubMed ID: 25414276
[TBL] [Abstract][Full Text] [Related]
32. Genomic Testing: a Genetic Counselor's Personal Reflection on Three Years of Consenting and Testing.
Wynn J
J Genet Couns; 2016 Aug; 25(4):691-7. PubMed ID: 26242468
[TBL] [Abstract][Full Text] [Related]
33. Content Analysis of Informed Consent for Whole Genome Sequencing Offered by Direct-to-Consumer Genetic Testing Companies.
Niemiec E; Borry P; Pinxten W; Howard HC
Hum Mutat; 2016 Dec; 37(12):1248-1256. PubMed ID: 27647801
[TBL] [Abstract][Full Text] [Related]
34. Whole-Exome Sequencing of 10 Scientists: Evaluation of the Process and Outcomes.
Lindor NM; Schahl KA; Johnson KJ; Hunt KS; Mensink KA; Wieben ED; Klee E; Black JL; Highsmith WE; Thibodeau SN; Ferber MJ; Aypar U; Ji Y; Graham RP; Fiksdal AS; Sarangi V; Ormond KE; Riegert-Johnson DL; McAllister TM; Farrugia G; McCormick JB
Mayo Clin Proc; 2015 Oct; 90(10):1327-37. PubMed ID: 26434960
[TBL] [Abstract][Full Text] [Related]
35. Counseling Close to Home: Genetic Counselors' Experiences with their own Family Members.
Rust L; Adamsheck H; Reiser CA; Petty EM
J Genet Couns; 2018 Feb; 27(1):225-240. PubMed ID: 28815348
[TBL] [Abstract][Full Text] [Related]
36. Parents perspectives on whole genome sequencing for their children: qualified enthusiasm?
Anderson JA; Meyn MS; Shuman C; Zlotnik Shaul R; Mantella LE; Szego MJ; Bowdin S; Monfared N; Hayeems RZ
J Med Ethics; 2017 Aug; 43(8):535-539. PubMed ID: 27888232
[TBL] [Abstract][Full Text] [Related]
37. The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience.
Lawrence L; Sincan M; Markello T; Adams DR; Gill F; Godfrey R; Golas G; Groden C; Landis D; Nehrebecky M; Park G; Soldatos A; Tifft C; Toro C; Wahl C; Wolfe L; Gahl WA; Boerkoel CF
Genet Med; 2014 Oct; 16(10):741-50. PubMed ID: 24784157
[TBL] [Abstract][Full Text] [Related]
38. Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine?
Jamuar SS; Kuan JL; Brett M; Tiang Z; Tan WL; Lim JY; Liew WK; Javed A; Liew WK; Law HY; Tan ES; Lai A; Ng I; Teo YY; Venkatesh B; Reversade B; Tan EC; Foo R
EBioMedicine; 2016 Mar; 5():211-6. PubMed ID: 27077130
[TBL] [Abstract][Full Text] [Related]
39. Attitudes Toward Discussing Approved and Investigational Treatments for Cystic Fibrosis in Prenatal Genetic Counseling Practice.
Elsas CR; Schwind EL; Hercher L; Smith MJ; Young KG
J Genet Couns; 2017 Feb; 26(1):63-71. PubMed ID: 27277131
[TBL] [Abstract][Full Text] [Related]
40. Responsibility, identity, and genomic sequencing: A comparison of published recommendations and patient perspectives on accepting or declining incidental findings.
Boardman F; Hale R
Mol Genet Genomic Med; 2018 Nov; 6(6):1079-1096. PubMed ID: 30370638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
